Health TrialsbyHealthPanel

French Validation of the Recovery Assessment Scale (RAS-FR)

ConditionsMental HealthPsychiatric Disorders
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorEtablissement Public de Santé Mentale de Metz-Jury

About this trial

The VAL-RAS-FR study aims to cross-culturally adapt, validate, and develop derived versions of the Recovery Assessment Scale (RAS), an internationally used self-report measure of subjective recovery in mental health. The study will include 260 adult psychiatric patients receiving care at EPSM Metz-Jury in both inpatient and outpatient settings. Participants will complete the French version of the RAS (RAS-FR), the WHOQOL-BREF, and additional self-report questionnaires. A subgroup of participants will complete the RAS-FR again after one month to assess test-retest reliability. The study will also explore existential aspects of recovery through the development of the RAS-FR-EX (Existential Extension) and support the development of a shorter version, the RAS-FR-SF (Short Form), for clinical and research purposes.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Adult patient (18 years or older)

Receiving psychiatric care at EPSM Metz-Jury (inpatient unit, day hospital, community mental health center [CMP], or intensive home-based psychiatric care service [EPSIAD]/post-EPSIAD follow-up)

Able to understand French

Able to complete a self-report questionnaire independently or with assistance if needed

Disqualifiers

Major cognitive impairment

Severe clinical condition preventing questionnaire completion or understanding of French

Refusal to participate

Prisoner or person deprived of liberty by judicial or administrative decision

Trial population

Adult psychiatric patients receiving care at EPSM Metz-Jury in inpatient units, day hospital settings, community mental health centers (CMP), or through intensive home-based psychiatric care services (EPSIAD). Participants are French-speaking adults able to complete self-report questionnaires independently or with assistance if needed. Patients under legal protection measures may participate in accordance with applicable regulations.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Self-report questionnaires

    Other intervention

    Participants complete self-report questionnaires including the French version of the Recovery Assessment Scale (RAS-FR), the WHOQOL-BREF, and complementary questionnaires related to subjective recovery. The study also includes the exploratory assessment of six additional existential items. A subgroup of 50 participants will complete the RAS-FR again after one month to assess test-retest reliability. No therapeutic intervention, modification of usual care, invasive procedure, or additional medical examination is involved.

Treatment groups

260 Participants
are divided into 1 treatment group
Group A: Adult psychiatric patients1 intervention

Trial outcomes

Primary outcomes

1

Recovery Assessment Scale - French Version (RAS-FR): Total Score, Internal Consistency, Factor Structure, and Test-Retest Reliability

The Recovery Assessment Scale - French Version (RAS-FR) is a 41-item self-report questionnaire assessing subjective recovery in mental health. Total scores range from 41 to 205, with higher scores indicating a higher level of subjective recovery. Psychometric analyses will include internal consistency, dimensional structure, and test-retest reliability.

Time frame
Baseline and 1 month

Secondary outcomes

1

Correlation between Recovery Assessment Scale - French Version (RAS-FR) and WHOQOL-BREF (World Health Organization Quality of Life - Brief Version) scores

Assessment of convergent validity through correlations between the Recovery Assessment Scale - French Version (RAS-FR) total score and WHOQOL-BREF domain scores in adult psychiatric patients, with particular attention to the psychological and social relationship domains. The RAS-FR total score ranges from 41 to 205, with higher scores indicating a higher level of subjective recovery. WHOQOL-BREF domain scores range from 0 to 100, with higher scores indicating better perceived quality of life. Pearson or Spearman correlation coefficients will be calculated.

Time frame
Baseline
2

Existential dimension of recovery (RAS-FR-EX) composite score

Exploratory assessment of the existential dimension of recovery using six additional items integrated into the French version of the Recovery Assessment Scale (RAS-FR-EX). A composite score ranging from 6 to 30 will be calculated, with higher scores indicating a stronger endorsement of existential recovery processes.

Time frame
Baseline
3

Development of a short-form Recovery Assessment Scale - French Version (RAS-FR-SF)

Exploratory item reduction analyses based on responses to the 41-item Recovery Assessment Scale - French Version (RAS-FR). The objective is to identify a shorter version of the instrument while preserving its psychometric properties and conceptual coverage of subjective recovery.

Time frame
Baseline

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Etablissement Public de Santé Mentale de Metz-Jury

Lead sponsor

Centre Hospitalier Régional Metz-Thionville

Collaborator

Groupement Interrégional de Recherche Clinique et d'Innovation

Collaborator

Source ClinicalTrials.gov
Apply now